Navigation Links
Pharmaceutical Insiders with Proof of Company’s Improper Relationships: Federal Law Offers Whistleblowers Opportunity for Sizable Financial Compensation, Parker Waichman LLP Says
Date:10/22/2013

New York, New York (PRWEB) October 22, 2013

Parker Waichman LLP, a national law firm that represents whistleblowers in qui tam cases, is looking to inform potential whistleblowers in the pharmaceutical industry that if they have proof of an improper relationship between their firm and a government entity, such as a regulating agency, financial opportunities abound, courtesy of the federal government.

One recent example involving a potential unlawful relationship between a regulator and one or more pharmaceutical companies centers on a scientific panel charged with shaping the federal government’s policy for testing the safety and effectiveness of painkillers. As The Washington Post reported on Oct. 6, 2013, major pharmaceutical companies funded the panel, paying hundreds of thousands of dollars for an opportunity “to affect the thinking” of the U.S. Food and Drug Administration (FDA), according to hundreds of emails that were obtained via a public records request.

The emails show, The Washington Post noted, that the pharmaceutical companies paid as much as $25,000 to attend panel meetings. Two medical professors, Robert Dworkin of the University of Rochester and Dennis Turk of the University of Washington, organized the panel, and as The Washington Post reported, the emails mainly described their efforts at financing and organizing the group and its meetings.

The Post article further noted that the FDA has been disparaged for failing to put in place stricter precautions that might have helped the U.S. to avoid the, “epidemic of addiction to prescription drugs,” such as Oxycontin and other opioids.

Sen. Joe Manchin III has s
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Global, common approach to pharmaceutical supply chain integrity the focus of workshop
2. MSU invention could help pharmaceutical industry save money
3. Nobel laureate to keynote international pharmaceutical conference at URI
4. 5 more pharmaceutical companies join NIH initiative to speed therapeutic discovery
5. Is it constitutional for states to regulate pharmaceutical gifts and meals to doctors?
6. Pharmica Consulting to Hold HIT Conference for the Pharmaceutical Industry
7. Scientists use sound waves to levitate liquids, improve pharmaceuticals
8. Medical care presents update on pharmaceutical health services research
9. Taiho Pharmaceutical unveils data on 8 novel anticancer compounds
10. Environmentally friendly chemistry important for manufacturing pharmaceuticals
11. Edison Pharmaceuticals announces initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... , ... July 02, 2015 , ... The ZAC Foundation, ... 2015 swim season with important lessons on how to stay water safe with the ... Couldn’t, Wouldn’t Swim, authored by The ZAC Foundation co-founders, follows Zeke’s water safety journey. ...
(Date:7/2/2015)... ... July 02, 2015 , ... Healthpointe ... to the orthopedic and spine surgery team at their Anaheim clinic. Dr. Krishnareddy ... tendonitis. Along with the spine and spine surgery, Dr. Krishnareddy also specializes in ...
(Date:7/2/2015)... ... July 02, 2015 , ... Breakthrough technologies are ... treatment. Dr. Lev Kalika, founder of New York Dynamic Neuromuscular Rehabilitation & ... the conservative treatment of back, hip, knee and shoulder pain as well as ...
(Date:7/2/2015)... ... July 02, 2015 , ... eHuman Digital Anatomy, the industry ... their flagship product, 3D Tooth Atlas, version 7.6. This release delivers new and ... videos. This latest release of the 3D Tooth Atlas offers a much faster ...
(Date:7/2/2015)... ... July 02, 2015 , ... After conducting a nationwide executive ... Medical Center in Yuma, Ariz., has hired Robert Trenschel, DO, as chief executive ... management, Dr. Trenschel will assume his new duties at Yuma Regional Medical Center on ...
Breaking Medicine News(10 mins):Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 2Health News:The ZAC Foundation Kicks Off Summer and July 4th Weekend with Complimentary Children’s E-Book on Water Safety 3Health News:Healthpointe Welcomes Dr. Divakar R. Krishnareddy to its Orthopedic Team in Anaheim 2Health News:Healthpointe Welcomes Dr. Divakar R. Krishnareddy to its Orthopedic Team in Anaheim 3Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 2Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 3Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 4Health News:eHuman Digital Anatomy Releases 3D Tooth Atlas version 7.6 2Health News:Yuma Regional Medical Center Hires New Chief Executive Officer 2Health News:Yuma Regional Medical Center Hires New Chief Executive Officer 3
... Ill., Aug. 3 In the midst of bad economic times, ... devoted efforts of hospital staff and the assistance of a healthcare ... Solutions . While competing hospitals in the area are seeing a ... Center has seen Volume Hours increase 8.5% over the last six months. ...
... , , LARGO, Fla., ... Venture Exchange: UVI) Board of Directors today declared its regular quarterly cash ... stockholders of record at the close of business on August 14, 2009. ... the U.S. $0.09 per share quarterly dividend, which on a annualized dividend ...
... digital mammography equipment alone is responsible for an increased ... facility, according to a study performed at San Luis ... Researchers found that there was a significant increase in ... from film-screen to digital mammography. The number of cancers ...
... international team of researchers has identified a new method ... to new areas for drug development in melanoma ... strategies. Researchers from Virginia Commonwealth University, in collaboration ... Soengas, Ph.D., with the Spanish National Cancer Research Center ...
... ... transitioning to an earlier sleep schedule to avoid losing sleep with an earlier wake time. ... the first day of school. , ... Atlanta, GA (PRWEB) August 3, 2009 -- The lazy days of summer are about ...
... /PRNewswire-FirstCall/ - Hard to Treat Diseases, Inc. (HTDS:PK), ... Slavica BioChem division have reported results on experiments ... oxygenation (HBO) after traumatic brain injury have been ... doctors from the Hyperbaric Medical Center, School of ...
Cached Medicine News:Health News:Compirion and Anderson Surgery Center Reduce OR Inefficiencies and Improve Finances 2Health News:Compirion and Anderson Surgery Center Reduce OR Inefficiencies and Improve Finances 3Health News:Compirion and Anderson Surgery Center Reduce OR Inefficiencies and Improve Finances 4Health News:Compirion and Anderson Surgery Center Reduce OR Inefficiencies and Improve Finances 5Health News:Compirion and Anderson Surgery Center Reduce OR Inefficiencies and Improve Finances 6Health News:Compirion and Anderson Surgery Center Reduce OR Inefficiencies and Improve Finances 7Health News:Compirion and Anderson Surgery Center Reduce OR Inefficiencies and Improve Finances 8Health News:Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U.S. $0.09 Per Share 2Health News:Parents Lose Sleep Too When Students Begin School, Says Atlanta Sleep Medicine Clinic 2Health News:Parents Lose Sleep Too When Students Begin School, Says Atlanta Sleep Medicine Clinic 3Health News:Parents Lose Sleep Too When Students Begin School, Says Atlanta Sleep Medicine Clinic 4Health News:Parents Lose Sleep Too When Students Begin School, Says Atlanta Sleep Medicine Clinic 5Health News:Hard to Treat Diseases, Inc. (HTDS) Experiments with Hyperbaric Oxygenation (HBO) Traumatic Brain Injury 2Health News:Hard to Treat Diseases, Inc. (HTDS) Experiments with Hyperbaric Oxygenation (HBO) Traumatic Brain Injury 3Health News:Hard to Treat Diseases, Inc. (HTDS) Experiments with Hyperbaric Oxygenation (HBO) Traumatic Brain Injury 4
(Date:7/2/2015)... BioLife Solutions , Inc. (NASDAQ: BLFS ), a leading ... tissue hypothermic storage and cryopreservation freeze ... management app for smart shippers ("BioLife" or ... has included BioLife in its annual list of the 100 ... for 2015. Now in its 24th ...
(Date:7/2/2015)... China   , July 2, 2015 /PRNewswire/ ... laboratory in Hong Kong has ... BGI Hong Kong facility is the first clinical next-generation-sequencing ... China , meeting the highest standard in clinical ... CFR Part 11 compliant laboratory process, and multiple ISO ...
(Date:7/2/2015)...   Wilson Therapeutics AB , a privately-held biopharmaceutical ... its board of directors. The appointment was approved by ... 30. "We are delighted to welcome Hans ... , CEO of Wilson Therapeutics. "Hans brings significant global ... to his contributions to the Company." Hans ...
Breaking Medicine Technology:BioLife Solutions Named One of the 100 Best Companies to Work For in Washington State 2BioLife Solutions Named One of the 100 Best Companies to Work For in Washington State 3BGI Receives Accreditation from the College of American Pathologists (CAP) 2Wilson Therapeutics Appoints Hans Schikan to its Board of Directors 2
... Pharmaceuticals, Inc. (Nasdaq: MAPP ) today announced the appointment ... Steven A. Elms, the incumbent Chairman and an original venture capital ... Directors after over six years of service. "I want ... the Board as we have grown from an early concept to ...
... Feb. 18, 2011 Tibotec Pharmaceuticals announced today that ... to examine TMC435, its investigational hepatitis C protease inhibitor, ... virus (HCV). A third global phase 3 trial is ... experienced a viral relapse after prior interferon-based treatment. Approximately ...
Cached Medicine Technology:MAP Pharmaceuticals Appoints Scott R. Ward as Chairman of the Board of Directors 2MAP Pharmaceuticals Appoints Scott R. Ward as Chairman of the Board of Directors 3Tibotec Starts Global Phase 3 Clinical Trials Studying TMC435 in Adults With Chronic Genotype 1 HCV 2Tibotec Starts Global Phase 3 Clinical Trials Studying TMC435 in Adults With Chronic Genotype 1 HCV 3Tibotec Starts Global Phase 3 Clinical Trials Studying TMC435 in Adults With Chronic Genotype 1 HCV 4Tibotec Starts Global Phase 3 Clinical Trials Studying TMC435 in Adults With Chronic Genotype 1 HCV 5
PT, PTT, Fibrinogetn & TT Normal and Abnormal Controls...
Fructosamine Calibrator...
ApolipoproteinA-1 & B Calibrator...
CRP Full Range (0.1-160mg/l)...
Medicine Products: